Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-21-000462
Filing Date
2021-08-13
Accepted
2021-08-13 12:27:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 aligos13g.htm SC 13G 58676
  Complete submission text file 0000935836-21-000462.txt   60217
Mailing Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

EIN.: 833997742 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91770 | Film No.: 211170903
SIC: 2836 Biological Products, (No Diagnostic Substances)